We use cookies on our website to provide you with a better service.
More info
Accept all
More options
Strictly necessary cookies
Language cookie
Marketing cookies
Facebook Pixel
Performance cookies
Google Analytics
YouTube
Vimeo
More info
Accept all
Ok
screenreader.back to home
screenreader.open offcanvas menu
Portfolio
Team
News
Contact
back to Capricorn Partners
Capricorn Health
News
rss feed
News
Stay up to date
year
by year
2022
2021
2020
2019
2018
2017
reset
2020
Sequana Medical announces first patient enrolled in RED DESERT – REpeated Dose alfapump® DSR study for Treatment of diuretic-resistant heart failure patients
7 January 2020
2019
Confo Therapeutics reports grant of two key patents for ConfoBodies™
2 December 2019
Sequana Medical announces first patient enrolled in North American alfapump® pivotal study (POSEIDON)
25 September 2019
FierceBiotech names Confo Therapeutics as one of its “Fierce 15” Biotech Companies of 2019
23 September 2019
iSTAR Medical announces € 40 million Series C financing
5 September 2019
Mainstay Medical announces completion of financing transactions
30 July 2019
iSTAR Medical’s MINIject shows consistent results at 18-month follow-up in first-in-human trial (STAR-I)
10 July 2019
Confo Therapeutics and DyNAbind announce drug discovery collaboration to identify novel GPCR-modulating compounds
3 July 2019
Mainstay Medical announces completion of pre-submission meeting with FDA regarding Pre-Market Approval (PMA) application for ReActiv8
26 June 2019
Confo Therapeutics raises € 30 million in Series A financing
7 May 2019
Professor Paul Fitzgerald joins Nexstim’s Scientific Advisory Board
24 April 2019
2018
iSTAR Medical’s MINIject maintains exceptional results in first-in-human trial one year post-surgery (STAR-I)
19 December 2018
1
2
3
4
5
